Neuberger Berman Group LLC Has $18.28 Million Stock Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Neuberger Berman Group LLC cut its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 4.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,310,815 shares of the company's stock after selling 61,820 shares during the period. Neuberger Berman Group LLC owned 4.75% of ZimVie worth $18,284,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Y Intercept Hong Kong Ltd acquired a new position in ZimVie during the 3rd quarter worth $528,000. Barclays PLC boosted its stake in ZimVie by 338.4% during the 3rd quarter. Barclays PLC now owns 43,437 shares of the company's stock worth $690,000 after purchasing an additional 33,529 shares during the period. Geode Capital Management LLC increased its position in ZimVie by 2.4% in the 3rd quarter. Geode Capital Management LLC now owns 646,564 shares of the company's stock valued at $10,263,000 after acquiring an additional 15,053 shares during the period. Principal Financial Group Inc. acquired a new stake in shares of ZimVie during the third quarter worth $275,000. Finally, JPMorgan Chase & Co. increased its stake in shares of ZimVie by 66.7% during the third quarter. JPMorgan Chase & Co. now owns 183,419 shares of the company's stock worth $2,911,000 after acquiring an additional 73,395 shares during the period. Hedge funds and other institutional investors own 95.63% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ZIMV. B. Riley initiated coverage on ZimVie in a report on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price on the stock. Needham & Company LLC reissued a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Stock Down 1.2 %

Shares of ZIMV traded down $0.11 during trading hours on Wednesday, reaching $9.19. The company's stock had a trading volume of 46,883 shares, compared to its average volume of 133,421. The company has a 50 day moving average of $11.79 and a two-hundred day moving average of $13.41. The company has a quick ratio of 1.38, a current ratio of 1.94 and a debt-to-equity ratio of 0.57. ZimVie Inc. has a 1-year low of $8.56 and a 1-year high of $22.40. The firm has a market cap of $255.91 million, a price-to-earnings ratio of -0.70 and a beta of 2.14.

ZimVie (NASDAQ:ZIMV - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. The business had revenue of $111.52 million for the quarter, compared to the consensus estimate of $113.67 million. As a group, research analysts predict that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.